Aditya Bagrodia

Perfect. So today, you know, it really is an honor, Todd. You had the distinct pleasure, I would imagine, of kind of spearheading the AUA-ASTRO consensus, SUO consensus on biochemical recurrence guidelines. And maybe just talk a little bit about that process. I mean, it's a big deal, right? We're like, we want to get in the guidelines, we want to get it paid for. And here's the guidelines.

Perfect. So today, you know, it really is an honor, Todd. You had the distinct pleasure, I would imagine, of kind of spearheading the AUA-ASTRO consensus, SUO consensus on biochemical recurrence guidelines. And maybe just talk a little bit about that process. I mean, it's a big deal, right? We're like, we want to get in the guidelines, we want to get it paid for. And here's the guidelines.

Perfect. So today, you know, it really is an honor, Todd. You had the distinct pleasure, I would imagine, of kind of spearheading the AUA-ASTRO consensus, SUO consensus on biochemical recurrence guidelines. And maybe just talk a little bit about that process. I mean, it's a big deal, right? We're like, we want to get in the guidelines, we want to get it paid for. And here's the guidelines.

Well, that's super cool. And this is the first BCR salvage therapy guideline, right? This is not a iteration or update. This is this is a tabula rasa.

Well, that's super cool. And this is the first BCR salvage therapy guideline, right? This is not a iteration or update. This is this is a tabula rasa.

Well, that's super cool. And this is the first BCR salvage therapy guideline, right? This is not a iteration or update. This is this is a tabula rasa.

It's awesome. It's super helpful. And, you know, I kind of half the time feel like guidelines are so vague, they're just like completely useless. But this one I thought was really, really tremendous, Todd. And I'm not just saying that. I've been fortunate to sit on a couple guidelines committee, and I feel like I'm the lucky guy that gets to fine tooth comb like an already like amazing document.

It's awesome. It's super helpful. And, you know, I kind of half the time feel like guidelines are so vague, they're just like completely useless. But this one I thought was really, really tremendous, Todd. And I'm not just saying that. I've been fortunate to sit on a couple guidelines committee, and I feel like I'm the lucky guy that gets to fine tooth comb like an already like amazing document.

It's awesome. It's super helpful. And, you know, I kind of half the time feel like guidelines are so vague, they're just like completely useless. But this one I thought was really, really tremendous, Todd. And I'm not just saying that. I've been fortunate to sit on a couple guidelines committee, and I feel like I'm the lucky guy that gets to fine tooth comb like an already like amazing document.

And my contributions are usually fairly incremental, I would say.

And my contributions are usually fairly incremental, I would say.

And my contributions are usually fairly incremental, I would say.

Did you put the pen to the paper? I mean, like, here's the draft, send it out.

Did you put the pen to the paper? I mean, like, here's the draft, send it out.

Did you put the pen to the paper? I mean, like, here's the draft, send it out.

Awesome, man. Well, let's jump into it. And before we started recording, I'd asked when you kind of came through and finished up, and I think we're roughly in the same vintage. And my opinion is it's been a very exciting time with, you know, tremendous advancements in our understanding, diagnostics, et cetera. And maybe I'll ask you, Todd, to take a walk down memory lane and

Awesome, man. Well, let's jump into it. And before we started recording, I'd asked when you kind of came through and finished up, and I think we're roughly in the same vintage. And my opinion is it's been a very exciting time with, you know, tremendous advancements in our understanding, diagnostics, et cetera. And maybe I'll ask you, Todd, to take a walk down memory lane and

Awesome, man. Well, let's jump into it. And before we started recording, I'd asked when you kind of came through and finished up, and I think we're roughly in the same vintage. And my opinion is it's been a very exciting time with, you know, tremendous advancements in our understanding, diagnostics, et cetera. And maybe I'll ask you, Todd, to take a walk down memory lane and

Even back to trainee, you know, how you thought about post-prostatectomy, biochemical recurrence to now. And that's a huge question. So, you know, don't overthink it.

Even back to trainee, you know, how you thought about post-prostatectomy, biochemical recurrence to now. And that's a huge question. So, you know, don't overthink it.